NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM) Article

cited authors

  • Wefel, Jeffrey S; Pugh, Stephanie; Gondi, Vinai; Brown, Paul D; Tome, Wolfgang; Armstrong, Terri S; Bruner, Deborah; Bovi, Joseph; Robinson, Cliff; Khuntia, Deepak; Grosshans, David; Konski, Andre; Roberge, David; Kundapur, Vijayananda; Devisetty, Kiran; Shah, Sunjay; Usuki, Kenneth; Anderson, Bethany; Mehta, Minesh P; Kachnic, Lisa

fiu authors

publication date

  • August 20, 2019

Digital Object Identifier (DOI)


  • 66


  • Supplement_1